Trying to conceive can feel like a complicated task. When pregnancy doesn’t happen as quickly as expected, hormone testing is often one of the first tools clinicians use to understand what’s going on.

These blood tests look at the chemical “messengers” that drive egg maturation, ovulation, uterine preparation, and other steps required for conception..

This guide explains the core hormone tests used in female fertility care, what each one shows, and how results are interpreted alongside your history.

You’ll also find practical notes on timing, how birth control can affect results, and India-specific FAQs (including approximate costs in INR).

The goal is to answer three questions:

(1) Are you ovulating?
(2) What is your ovarian response likely to be if you need treatment?
(3) Are there correctable hormonal conditions like thyroid or prolactin issues affecting cycles?

Professional guidance emphasizes changing tests to history and cycle patterns, not ordering everything for everyone. For example, mid-luteal progesterone confirms ovulation; early-cycle FSH/estradiol or AMH gauge ovarian reserve; and TSH/prolactin are checked when symptoms or cycle irregularity suggest a problem.

A mid-luteal progesterone blood test (commonly nicknamed the “day-21 test,” but better timed as ~7 days after ovulation) confirms that ovulation occurred. Progesterone peaks six to eight days post-ovulation; the exact calendar day varies with cycle length, so timing the test to your luteal phase rather than a fixed day is more accurate.

If your cycles are irregular, your clinician may pair bloodwork with ovulation-tracking methods or ultrasound to time the draw correctly.

Adequate progesterone means an egg was released and the uterine lining received the hormonal signal to prepare for implantation. Persistently low values suggest anovulation (no egg release) in that cycle and prompt further evaluation or ovulation induction strategies.

Ovarian reserve tests estimate how the ovaries may respond to stimulation; they do not directly predict your ability to conceive naturally. The two most used are anti-Müllerian hormone (AMH, any day of the cycle) and a day-2–4 pair of FSH and estradiol.

AMH and antral follicle count (seen on ultrasound) are strong indicators of expected egg yield in IVF, while day-3 FSH/E2 provide a traditional check on early-cycle signaling. However, low AMH alone does not mean you cannot get pregnant without treatment; its predictive value for natural conception is limited.

Reserve testing helps set realistic expectations, individualize medication doses, and flag extremes (very low response or risk of over-response). Current guidance stresses using AMH/AFC primarily to counsel about stimulation and retrieval numbers, not to forecast whether you will conceive on your own or to screen people not seeking fertility care.

Few Factors to Consider

Urine LH kits detect the pre-ovulatory surge to time intercourse/IUI but are not diagnostic of broader fertility problems.

In irregular cycles or polycystic ovary syndrome (PCOS), elevated baseline LH can make kits less reliable; pairing with ultrasound or serum progesterone confirmation improves accuracy. Clinical guidance treats LH kits as adjuncts for timing rather than stand-alone tests.

A TSH (and, when indicated, free T4) checks for hypo- or hyperthyroidism that can disturb ovulation, luteal function, and miscarriage risk.

Subclinical thyroid problems sometimes show up first as cycle changes or difficulty conceiving; treating overt thyroid disease benefits overall reproductive outcomes. TSH is a standard part of the work-up when history or symptoms point that way.

An elevated prolactin level can disrupt the normal GnRH-LH/FSH pulses and lead to irregular cycles or anovulation.

Testing is usually done in the morning, ideally fasting and avoiding breast stimulation/exam just before the draw; significantly high results are repeated and evaluated for physiologic, medication-related, thyroid, renal, or pituitary causes. Treating the underlying cause often restores ovulation.

If you have excess hair growth, acne, or very irregular cycles, clinicians may check total/free testosterone, DHEA-S, and sometimes 17-hydroxyprogesterone. The aim is to distinguish common PCOS from less common adrenal or ovarian androgen excess.

Addressing androgen-related cycle dysfunction can improve ovulation frequency and pregnancy chances, either spontaneously or with ovulation induction.

Besides day-3 estradiol (interpreted with FSH), mid-cycle estradiol helps track follicle growth during treatment cycles.

As a diagnostic tool outside treatment, estradiol is most informative when paired with timing, ultrasound findings, and other hormones rather than used alone. Guidance does not recommend estradiol as a single predictor of natural fertility outcomes.

Different circumstances require different strategies, for instance:

• Regular cycles, <35 years, trying for more than 12 months: Mid-luteal progesterone to confirm ovulation; consider TSH and prolactin based on symptoms; reserve testing if treatment is being planned or to anticipate response.
• Irregular or absent periods: Check TSH, prolactin, FSH/LH (and androgens if PCOS suspected); confirm if/when ovulation occurs; reserve tests as indicated for planning.
• Planning IVF or egg freezing: AMH and/or AFC plus day-3 FSH/E2 guide dosing and expectations.

Abnormal results guide targeted action to treat correctable conditions (thyroid disease, hyperprolactinemia), address lifestyle or medication factors, and choose appropriate fertility treatment (e.g., ovulation induction for anovulation.

IVF with tailored stimulation for low or high ovarian response). The interpretation is always personalized, and one off-range number rarely tells the whole story.

Hormonal IUDs and pills can alter bleeding patterns and some lab values (notably AMH) while you’re using them, which complicates interpretation. If you’re evaluating ovulation or reserve while on contraception, your clinician will decide whether to test now (with caveats) or pause the method and retest after a washout period. Copper IUDs have fewer hormonal effects but can still complicate timing of certain tests.

Hormone tests are very useful but it is important to know to what extent, for instance:

• Guarantee natural conception: Low AMH does not automatically mean you can’t conceive on your own; high AMH does not guarantee quick conception.
• Replace age as a key factor: Age remains the most powerful predictor of egg quality and overall chances per cycle. Reserve tests are complements, not substitutes.